Literature DB >> 24625799

Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.

Giovanna Viticchi1, Lorenzo Falsetti2, Fabrizio Vernieri3, Claudia Altamura3, Riccardo Altavilla3, Simona Luzzi1, Marco Bartolini1, Leandro Provinciali1, Mauro Silvestrini1.   

Abstract

The presence of apolipoprotein E (APOE) ε4 allele is the only recognized genetic risk factor for the sporadic form of Alzheimer's disease. The aim of this study was to investigate the relationship between APOE genotype and the functional and anatomic status of cerebral vessels in patients with mild cognitive impairment (MCI). Moreover, we explored whether the possible correlation between APOE genotype and cerebrovascular parameters influences the risk of conversion from MCI to dementia. 75 MCI patients underwent a complete neuropsychological battery at baseline and after 24 months to evaluate the possible conversion to dementia. Ultrasound assessment of neck and intracranial vessels was performed to assess common carotid artery intima-media thickness (IMT), plaque index, and cerebrovascular reactivity (breath-holding index, BHI). APOE genotype was determined to classify patients as carriers (APOE ε4+) and non-carriers (APOE ε4-). Pathologic values of BHI and IMT were significantly more common in ε4 carriers than in non-carriers [OR 6.603 (95% CI: 1.678-25.997), p < 0.05 and OR 5.195 (95% CI 1.319-20.464), p < 0.05; logistic regression adjusted model]. The risk of conversion to dementia was significantly higher in APOE ε4+ patients than in APOE ε4- ones (OR: 6.818; 95% CI:1.894-24.545, p = 0.003). A path-analysis model showed that APOE genotype influences the progression to dementia directly and indirectly by increasing the risk of pathologic values of IMT or BHI. Our data, besides confirming an increased susceptibility of MCI patients with APOE ε4 to develop dementia, show an association between functional and anatomic impairment of the cerebral vessels and APOE ε4+ genotype.

Entities:  

Keywords:  Alzheimer's disease; apolipoproteins E; cerebrovascular diseases; cognition; ultrasonography

Mesh:

Substances:

Year:  2014        PMID: 24625799     DOI: 10.3233/JAD-132480

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Andreea L Seritan; Kyoungmi Kim; Ian Benjamin; Ioana Seritan; Randi J Hagerman
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-09-21       Impact factor: 2.680

2.  Evaluation of APOE Genotype and Ability to Perform Activities of Daily Living Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lacey Wright Heinsberg; Eleanor Turi; Dianxu Ren; Elizabeth Crago; Sheila Alexander; Ansley Grimes Stanfill; Yvette Perry Conley
Journal:  Biol Res Nurs       Date:  2017-12-19       Impact factor: 2.522

Review 3.  Impact of carotid stenosis on cerebral hemodynamic failure and cognitive impairment progression: a narrative review.

Authors:  Giovanna Viticchi; Lorenzo Falsetti; Eleonora Potente; Marco Bartolini; Mauro Silvestrini
Journal:  Ann Transl Med       Date:  2021-07

Review 4.  Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.

Authors:  Branko Malojcic; Panteleimon Giannakopoulos; Farzaneh A Sorond; Elsa Azevedo; Marina Diomedi; Janja Pretnar Oblak; Nicola Carraro; Marina Boban; Laszlo Olah; Stephan J Schreiber; Aleksandra Pavlovic; Zsolt Garami; Nantan M Bornstein; Bernhard Rosengarten
Journal:  BMC Med       Date:  2017-02-09       Impact factor: 8.775

Review 5.  Carotid Atherosclerosis and Cognitive Impairment in Nonstroke Patients.

Authors:  Wei-Hong Chen; Wei Jin; Pei-Yuan Lyu; Yang Liu; Rui Li; Ming Hu; Xiang-Jian Xiao
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

6.  Mapping cerebral pulse pressure and arterial compliance over the adult lifespan with optical imaging.

Authors:  Chin Hong Tan; Kathy A Low; Tania Kong; Mark A Fletcher; Benjamin Zimmerman; Edward L Maclin; Antonio M Chiarelli; Gabriele Gratton; Monica Fabiani
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

Review 7.  Shared Molecular Mechanisms among Alzheimer's Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Emanuele Guerrieri; Gianluca Moroncini; Simona Luzzi; Mauro Silvestrini
Journal:  Biomedicines       Date:  2022-02-14

8.  A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise.

Authors:  Dreu White; Casey S John; Ashley Kucera; Bryce Truver; Rebecca J Lepping; Paul J Kueck; Phil Lee; Laura Martin; Sandra A Billinger; Jeffrey M Burns; Jill K Morris; Eric D Vidoni
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.996

Review 9.  Effects of Plasma Lipids and Statins on Cognitive Function.

Authors:  Rui Li; Tian-Jun Wang; Pei-Yuan Lyu; Yang Liu; Wei-Hong Chen; Ming-Yue Fan; Jing Xu
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

10.  Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.

Authors:  Xunwei Deng; Jingyuan Hou; Qiaoting Deng; Zhixiong Zhong
Journal:  Lipids Health Dis       Date:  2021-09-29       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.